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Background: Blood stream infections are an important cause of
morbidity and mortality especially in febrile neutropenic patients.
Escherichia coli (E. coli) is a pathogen of great concern in immuno-
suppressedpatients.On timediagnosis andappropriatemedication
will be the best way to save the lives of the affected ones.
Methods & Materials: The objective of the study is to describe
the pattern of bacterial isolates from Blood cultures with special
reference to E. coli as an important pathogen and to determine the
antibiotic susceptibility pattern of E. coli. This is a retrospective
analysis of 1455 Blood cultures collected from clinically suspected
cases of bacteremia between Jan 2014- Oct 2015 in a cancer hos-
pital. The isolates were identiﬁed by standard biochemical tests
and also by fully Automated BD phoenix instrument. Antimicrobial
susceptibility was done by the Kirby bauer disk diffusion method
following the standard CLSI guidelines.
Results: Positive cultures were obtained in 376 (25.84%)cases.
Among culture positive isolates, Gram negative bacteria accounted
for 51.59%, most common being E. coli (25.79%) followed by
pseudomonas species (7.71%). Out of 97 non- repetitive E. coli
isolated 76.2% were sensitive to Amikacin, 79.38% were sensitive
to Imipenem, 45.36% were sensitive to Piperacillin + Tazobactum
& 46.39% were sensitive to Cefaperazone + Sulbactum. 87.63% of
E. coli isolateswere resistant toLevoﬂoxacinandCefepime&74.23%
were resistant to trimethoprim and sulphamethoxazole.
Conclusion: E. coli is a major pathogen in hematologic malig-
nancy patients with neutropenia. As part of their treatment
regimens, such patients are exposed to chemotherapy, radiation,
and antimicrobials in a short time period. As a result, the equilib-
rium between the intestinal microbiota and mucosal epithelium is
disrupted, causing large shifts in bacterial populations inhabiting
the gut thus making the patient susceptible to bloodstream infec-
tions. Fluoroquinolones, are widely used to protect these patients
against Gram-negative bacteremia. Increasing resistance to Fluro-
quinolones is alarming. In future treatingneutropenic patientswith
hematologic malignancies may deal with monitoring microbial gut
diversity through treatment. whether monitoring these microbial
shifts help us treat or prevent MDR E.coli bacteremia in these
patients remains unanswered.
http://dx.doi.org/10.1016/j.ijid.2016.02.233
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Background: Background: Quinolone group of antibiotics are
predominantly used drugs for treatment of urinary tract infections.
However, in recent decade’s treatment failure to this drug is due to
bacterial adaptation by acquisition of plasmid mediated quinolone
resistance determinants. There also exists an intrinsic resistance
mechanism bymutational changes in bacteria in type II and type IV
bacterial topoisomerase. The study was designed to analysis point
mutation in the gyrA and parC gene leading quinolone resistance
in uropathogenic Eshcerichia coli from community settings.
Methods & Materials: Materials and methods: A total of 113
quinolone resistant enterobacterial isolates were collected from
the urine of patient diagnosed with urinary tract infection from
different community health centre of southern Assam during July
2013 to June 2014. All the isolates were investigated for mutations
in the topoisomerases genes gyrA and parC by PCR ampliﬁcation
andampliconswereanalysed forpolymorphismbyDenaturinggra-
dient gel electrophoresis. MIC to ﬂuoroquinolones was tested by
the agar dilution method and results were interpreted as per CLSI
guidelines.
Results: Results: Amongst the 113 enterobacterial isolates, 98
(86.72%) were resistant to norﬂoxacin, 92 (81.41%), 57 (50.44%)
and 35(30.93%) showed reduced susceptibility to ciproﬂoxacin,
oﬂoxacin and levoﬂoxacin respectively. Several alterations were
detected in gyrA and parC genes. Five different type of mutation
in gyrA were detected in 94 isolates and 67 isolates were found to
have mutation in parC. This study also demonstrated the mutation
inquinolone resistancedetermining regionof gyrAand/or parCwas
associated with the MIC above the breakpoint for quinolone group
of antibiotics.
Conclusion: Conclusion: The present study is of epidemio-
logical interest and describes bacterial adaptation and genetic
modiﬁcation towards quinolone resistance. This study advocates
urgent measures to be taken to stop over the counters availability
of quinolone in this region and their misuse.
http://dx.doi.org/10.1016/j.ijid.2016.02.234
